Found 38 matching trials
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma EARLY_PHASE1 The purpose of this study is to determine if the combination of G-CSF and b...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma PHASE2 RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma NA This clinical trial studies peripheral blood hemapoietic stem cell mobiliza...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma PHASE2 The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM) PHASE3 Thalidomide-Dexamethasone (TD) is a standard induction therapy for Multiple...
Show More Location
AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
Learn More & Join Trial
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease PHASE4 The investigators' purpose was to assess the feasibility of dosage individu...
Show More Location
Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma PHASE1 Incorporation of rituximab to conventional chemotherapy (R-CHOP) has revolu...
Show More Location
Singapore General Hospital
Learn More & Join Trial
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib PHASE3 Standard treatment for AL Amyloidosis is high-dose melphalan and stem cell ...
Show More Location
Boston Medical Center
Learn More & Join Trial
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma PHASE2 RATIONALE: Herpesvirus is found in the cancer cells of patients with primar...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial